| scholarly article | Q13442814 |
| P356 | DOI | 10.1542/PEDS.112.4.896 |
| P953 | full work available at URL | https://publications.aap.org/pediatrics/article-pdf/112/4/896/1013665/pe1003000896.pdf |
| P698 | PubMed publication ID | 14523183 |
| P5875 | ResearchGate publication ID | 9068969 |
| P2093 | author name string | Stephanie Läer | |
| Jochen Weil | |||
| Reinhard Laux | |||
| Thomas S. Mir | |||
| Bozena Liedke | |||
| Cornelius Heinze | |||
| Hans Henning Hellwege | |||
| Helmut von Buelow | |||
| P2860 | cites work | Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children--a three year follow up | Q72785737 |
| Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations | Q73736775 | ||
| Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension | Q74206355 | ||
| Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide | Q34184637 | ||
| Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy | Q34563544 | ||
| Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart | Q34564865 | ||
| Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure | Q40618681 | ||
| Brain natriuretic peptide versus atrial natriuretic peptide--physiological and pathophysiological significance in children and adults: a review | Q41187797 | ||
| Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure | Q46198715 | ||
| A new natriuretic peptide in porcine brain | Q48100804 | ||
| Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice | Q48112030 | ||
| Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. | Q48242684 | ||
| Cardiac transplantation affects ventricular expression of brain natriuretic peptide | Q48334600 | ||
| Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators | Q48536547 | ||
| Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension | Q48540754 | ||
| Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment | Q48592649 | ||
| Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure | Q48643573 | ||
| Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body | Q67297603 | ||
| Brain natriuretic peptide is a novel cardiac hormone | Q69293904 | ||
| Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases | Q70020453 | ||
| The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma | Q71780723 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 896-899 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Pediatrics | Q7159238 |
| P1476 | title | Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth | |
| P478 | volume | 112 |
| Q37223212 | Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease |
| Q48534455 | Amino terminal pro B-type natriuretic peptide levels are elevated in the cord blood of neonates with congenital heart defect |
| Q36856379 | Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? |
| Q92177448 | B-Type Cardiac Natriuretic Peptides in the Neonatal and Pediatric Intensive Care Units |
| Q35968889 | B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. |
| Q58605448 | B-type natriuretic peptide reference interval of newborns from healthy and pre-eclamptic women: a prospective, multicentre, cross-sectional study |
| Q38324210 | BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? |
| Q39030343 | Cardiac biomarkers in pediatric heart disease: A state of art review |
| Q48483733 | Cerebral tissue oxygen saturation is associated with N-terminal probrain natriuretic peptide in preterm infants on their first day of life |
| Q38310280 | Current applications and Future Needs for Biomarkers in Pediatric Cardiomyopathy and Heart Failure: Summary From The Second International Conference On Pediatric Cardiomyopathy. |
| Q33810576 | Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases. |
| Q48832604 | Distribution of circulating cardiac biomarkers in healthy children: from birth through adulthood. |
| Q52149107 | Does preeclampsia have any adverse effect on fetal heart? |
| Q47722553 | Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus |
| Q89780197 | Follow-up of isolated congenital complete atrioventricular block with longitudinal measurements of serum NT-proBNP and cardiothoracic ratio |
| Q48806008 | Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease |
| Q64264437 | N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Bronchopulmonary Dysplasia or Death in Preterm Infants: A Retrospective Cohort Analysis |
| Q46237102 | N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants |
| Q36862707 | N-terminal probrain natriuretic peptide level inversely correlates with cardiac index after arterial switch operation in neonates. |
| Q33348965 | NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies |
| Q39165884 | NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study. |
| Q39332205 | Non-shivering thermogenesis as a mechanism to facilitate sustainable weight loss |
| Q43968441 | Old tool - new application: NT-proBNP in fetal medicine |
| Q46743486 | Ontogeny of atrial natriuretic peptide and its receptor in the lung: effects on perinatal surfactant release. |
| Q36797141 | Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals |
| Q44237599 | Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies |
| Q51594468 | Plasma B-type natriuretic peptide levels in children with heart disease. |
| Q48875679 | Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus |
| Q48796084 | Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender |
| Q61807150 | Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure-A Comparative Review |
| Q37748955 | Practical application of natriuretic peptides in paediatric cardiology. |
| Q44929314 | Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform. |
| Q48865786 | Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children |
| Q40183631 | Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study |
| Q33580726 | The Use of N-Terminal-Pro-BNP in Preterm Infants |
| Q44351659 | The efficacy of cardiac findings in assessing the outcome in preterms with bronchopulmonary dysplasia |
| Q38182858 | The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. |
| Q87246873 | The relationship between BNP, NTproBNP and echocardiographic measurements of systemic blood flow in very preterm infants |
| Q35077539 | The sexual dimorphism of obesity |
| Q38026430 | Use of cardiac biomarkers in neonatology |
| Q46878625 | Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery |
Search more.